Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trinity J Bivalacqua

Showing results (51-60 of 395) with videos related to

Pageof 40
Sort By:
The Journal of Sexual Medicine|November 21, 2013
Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penisBiljana Musicki, Trinity J Bivalacqua, Hunter C Champion, et al.
Current Drug Targets|May 8, 2015
Pathophysiology of erectile dysfunctionHotaka Matsui, Nikolai A Sopko, Johanna L Hannan, et al.
Current Drug Targets|March 10, 2015
Mini Review: Pathophysiology of Erectile DysfunctionHotaka Matsui, Nikolai A Sopko, Johanna L Hannan, et al.
Surgery|October 7, 2011
Arginase inhibition promotes wound healing in miceSandra L Kavalukas, Aarti R Uzgare, Trinity J Bivalacqua, et al.
The Journal of Sexual Medicine|November 15, 2006
Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapismArthur L Burnett, Trinity J Bivalacqua, Hunter C Champion, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2015
New Strategies in Bladder Cancer: A Second Coming for ImmunotherapyAli Ghasemzadeh, Trinity J Bivalacqua, Noah M Hahn, et al.
Urology|May 16, 2006
Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapismArthur L Burnett, Trinity J Bivalacqua, Hunter C Champion, et al.
Urologic Oncology|December 24, 2021
Race, ethnicity, and gender reporting in North American clinical trials for BCG-unresponsive non-muscle invasive bladder cancerSean A Fletcher, Trinity J Bivalacqua, Otis W Brawley, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 2, 2019
Predictive biomarkers for drug response in bladder cancerTakahiro Yoshida, Max Kates, Kazutoshi Fujita, et al.
Urology Practice|April 2, 2024
Reply by AuthorsTaylor P Kohn, William DuComb, Kiran Sury, et al.
Pageof 40

Showing results (51-60 of 395) with videos related to

Sort By:
Pageof 40
The Journal of Sexual Medicine|November 21, 2013
Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penisBiljana Musicki, Trinity J Bivalacqua, Hunter C Champion, et al.
Current Drug Targets|May 8, 2015
Pathophysiology of erectile dysfunctionHotaka Matsui, Nikolai A Sopko, Johanna L Hannan, et al.
Current Drug Targets|March 10, 2015
Mini Review: Pathophysiology of Erectile DysfunctionHotaka Matsui, Nikolai A Sopko, Johanna L Hannan, et al.
Surgery|October 7, 2011
Arginase inhibition promotes wound healing in miceSandra L Kavalukas, Aarti R Uzgare, Trinity J Bivalacqua, et al.
The Journal of Sexual Medicine|November 15, 2006
Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapismArthur L Burnett, Trinity J Bivalacqua, Hunter C Champion, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2015
New Strategies in Bladder Cancer: A Second Coming for ImmunotherapyAli Ghasemzadeh, Trinity J Bivalacqua, Noah M Hahn, et al.
Urology|May 16, 2006
Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapismArthur L Burnett, Trinity J Bivalacqua, Hunter C Champion, et al.
Urologic Oncology|December 24, 2021
Race, ethnicity, and gender reporting in North American clinical trials for BCG-unresponsive non-muscle invasive bladder cancerSean A Fletcher, Trinity J Bivalacqua, Otis W Brawley, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 2, 2019
Predictive biomarkers for drug response in bladder cancerTakahiro Yoshida, Max Kates, Kazutoshi Fujita, et al.
Urology Practice|April 2, 2024
Reply by AuthorsTaylor P Kohn, William DuComb, Kiran Sury, et al.
Pageof 40